BioNTech’s Bold Evolution: From Vaccine Giant to Cancer-Fighting Pioneer
BioNTech shifts focus from COVID-19 vaccines to pioneering cancer treatments using mRNA technology. Financial results for 2024 showed a decrease in earnings and revenue, yet surpassed market expectations. The company…